Ken‐ichi Kusakabe - Concepedia

Author

Ken‐ichi Kusakabe

Also Known As

K KUSAKABE, K Kusakabe, K. KUSAKABE, K. Kusakabe, K.I. Kusakabe, Ken-ichi Kusakabe, Kenichi Kusakabe, Ken‐ichi Kusakabe, Kodai Kusakabe, Kusakabe, K

Publications

Citations

H-Index

Concepts

All Affiliations

Shionogi (Japan)Futaba (Japan)Janssen (Belgium)The University of Tokyo Shiga University of Medical Science

About

Ken‐ichi Kusakabe is an author at Shionogi (Japan) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	304
2	Engineering	7	7	437
3	Natural Sciences	7	7	268
4	Biochemistry	6	6	222
5	Applied Physics	2	2	69

Ken‐ichi Kusakabe

Publications

903

Citations

H-Index

Page 1

	Year	Citations
A Switch of Enantiofacial Selectivities Using Designed Similar Chiral Ligands in Zirconium-Catalyzed Asymmetric Aza Diels−Alder Reactions Shu̅ Kobayashi, Ken‐ichi Kusakabe, Susumu Komiyama, The Journal of Organic Chemistry Inorganic ChemistryChemical EngineeringEngineeringAromatic CompoundsDonut Icon	1999	114
Chiral Catalyst Optimization Using Both Solid-Phase and Liquid-Phase Methods in Asymmetric Aza Diels−Alder Reactions Shu̅ Kobayashi, Ken‐ichi Kusakabe, Haruro Ishitani Organic Letters EngineeringOrganic ChemistryChemistryRapid OptimizationPolymers	2000	88
Synthesis of ethane and ethylene from methane and carbon dioxide over praseodymium oxide catalysts Kenji Asami, Ken‐ichi Kusakabe, Naobumi Ashi, Applied Catalysis A General Carbon DioxideChemical EngineeringCatalytic ApplicationEngineeringOrganic Chemistry	1997	82
Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity Ken‐ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineOrally Available Mps1Natural Sciences	2015	64
Conversion of methane with carbon dioxide into C2 hydrocarbons over metal oxides Kenji Asami, Taikyu Fujita, Ken‐ichi Kusakabe, Applied Catalysis A General Carbon DioxideCarbon SequestrationChemical EngineeringMetal OxidesGas Conversion	1995	60
Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial Yuji Koriyama, Akihiro Hori, Hisanori Ito, Journal of Medicinal Chemistry	2021	48
Molecular Dynamics Simulation of Friction of Hydrocarbon Thin Films Hiroyuki Tamura, Muneo Yoshida, Ken‐ichi Kusakabe, Langmuir EngineeringMechanical EngineeringHydrocarbon Thin FilmsChemistrySoft Matter	1999	47
Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125) Ken‐ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, Journal of Medicinal Chemistry Molecular BiologyPharmacotherapySelective Mps1 InhibitorsIndazole-based PotentTumor Biology	2013	46
Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists Ken‐ichi Kusakabe, Yukio Tada, Yasuyoshi Iso, Bioorganic & Medicinal Chemistry Medicinal ChemistryDrug TargetBiochemistryFunctional SelectivityMedicine	2013	38
Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2 Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Journal of Medicinal Chemistry Drug TargetProtein AssemblyMolecular BiologyChemical BiologyPharmaceutical Chemistry	2019	35

Page 1